Botanical species · safety record

Fragaria vesca

The EFSA Compendium of Botanicals holds 9 constituent measurements and 1 genotoxicity assay for Fragaria vesca. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Fragaria vesca L.

9Constituent measurements

1Safety records

3Cited sources

37Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 37 licensed products naming Fragaria vesca as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Dried ripe fruit
Fragaria vesca - Fruit
Fruit
Leaf
Ripe fruit and root
Ripe fruit(s)
Tincture of ripe fruit
Whole plant

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Agrimoniin	Fruit unspecified	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Lambertianin c	Fruit unspecified	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Sanguiin h-6	Fruit unspecified	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Agrimoniin	Leaves	Solvent extraction	≤ 1.11 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Agrimoniin	Leaves	Solvent extraction	≥ 0.89 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Gallic acid	Leaves	Solvent extraction	≥ 0.11 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Gallic acid	Leaves	Solvent extraction	≤ 0.16 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Pedunculagin	Leaves	Solvent extraction	≥ 0.4 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Pedunculagin	Leaves	Solvent extraction	≤ 0.68 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier

Genotoxicity testing

Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.

Outcome	Endpoint	Test	Tested organism	Metabolic activation	Source
Positive	gene mutation	bacterial reverse mutation assay	Saccharomyces cerevisiae (as organism)	Not applicable	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Fecka, Izabela. Development of chromatographic methods for determination of agrimoniin and related polyphenols in pharmaceutical products. Journal of AOAC International, 2009, p. 410-418.
Spada, Patrcia D. S., Nunes de Souza, Gabrielle Gianna., Bortolini, Giovana Vera., Henriques, Joo A. P., Salvador, Mirian. Antioxidant, Mutagenic, and Antimutagenic Activity of Frozen Fruits. Journal of medicinal food, 2008, p. 144-151.
Vrhovsek, Urska., Guella, Graziano., Gasperotti, Mattia., Pojer, Elisa., Zancato, Mirella., Mattivi, Fulvio. Clarifying the Identity of the Main Ellagitannin in the Fruit of the Strawberry, Fragaria vesca and Fragaria ananassa Duch.. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2012, vol. 60, no. 10, p. 2507-2516. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature